Sex differences in the 10-year survival of patients undergoing maintenance hemodialysis in the Q-Cohort Study

被引:1
|
作者
Tsujikawa, Hiroaki [1 ]
Yamada, Shunsuke [1 ]
Hiyamuta, Hiroto [1 ]
Taniguchi, Masatomo [2 ]
Tsuruya, Kazuhiko [3 ]
Torisu, Kumiko [1 ,4 ]
Nakano, Toshiaki [1 ]
Kitazono, Takanari [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan
[2] Fukuoka Renal Clin, Fukuoka, Japan
[3] Nara Med Univ, Dept Nephrol, Nara, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka, Japan
关键词
REPLACEMENT THERAPY; DIALYSIS PATIENTS; MORTALITY; WOMEN; INFECTIONS; ESTROGEN; GENDER; BLOOD;
D O I
10.1038/s41598-021-03551-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Women have a longer life expectancy than men in the general population. However, it has remained unclear whether this advantage is maintained in patients undergoing maintenance hemodialysis. The aim of this study was to compare the risk of mortality, especially infection-related mortality, between male and female hemodialysis patients. A total of 3065 Japanese hemodialysis patients aged >= 18 years old were followed up for 10 years. The primary outcomes were all-cause and infection-related mortality. The associations between sex and these outcomes were examined using Cox proportional hazards models. During the median follow-up of 8.8 years, 1498 patients died of any cause, 387 of whom died of infection. Compared with men, the multivariable-adjusted hazard ratios (95% confidence interval) for all-cause and infection-related mortality in women were 0.51 (0.45-0.58, P < 0.05) and 0.36 (0.27-0.47, P < 0.05), respectively. These findings remained significant even when propensity score-matching or inverse probability of treatment weighting adjustment methods were employed. Furthermore, even when the non-infection-related mortality was considered a competing risk, the infection-related mortality rate in women was still significantly lower than that in men. Regarding all-cause and infection-related deaths, women have a survival advantage compared with men among Japanese patients undergoing maintenance hemodialysis.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] History of fragility fracture is associated with cardiovascular mortality in hemodialysis patients: the Q-Cohort study
    Haruyama, Naoki
    Nakayama, Masaru
    Yamada, Shunsuke
    Tanaka, Shigeru
    Hiyamuta, Hiroto
    Taniguchi, Masatomo
    Tokumoto, Masanori
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    Nakano, Toshiaki
    JOURNAL OF BONE AND MINERAL METABOLISM, 2024, 42 (02) : 253 - 263
  • [22] Malnutrition-Inflammation Complex Syndrome and Bone Fractures and Cardiovascular Disease Events in Patients Undergoing Hemodialysis: The Q-Cohort Study
    Yamada, Shunsuke
    Arase, Hokuto
    Yoshida, Hisako
    Kitamura, Hiromasa
    Tokumoto, Masanori
    Taniguchi, Masatomo
    Hirakata, Hideki
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    KIDNEY MEDICINE, 2022, 4 (03)
  • [23] Association of hyperphosphatemia with an increased risk of sudden death in patients on hemodialysis: Ten-year outcomes of the Q-Cohort Study
    Hiyamuta, Hiroto
    Yamada, Shunsuke
    Taniguchi, Masatomo
    Tokumoto, Masanori
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    ATHEROSCLEROSIS, 2021, 316 : 25 - 31
  • [24] Modified creatinine index and risk for cardiovascular events and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort study
    Arase, Hokuto
    Yamada, Shunsuke
    Yotsueda, Ryusuke
    Taniguchi, Masatomo
    Yoshida, Hisako
    Tokumoto, Masanori
    Nakano, Toshiaki
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    ATHEROSCLEROSIS, 2018, 275 : 115 - 123
  • [25] Association between hyporesponsiveness to erythropoiesis-stimulating agents and risk of brain hemorrhage in patients undergoing hemodialysis: the Q-Cohort Study
    Uchida, Yushi
    Nakano, Toshiaki
    Kitamura, Hiromasa
    Taniguchi, Masatomo
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 27 (01) : 79 - 88
  • [26] Association between hyporesponsiveness to erythropoiesis-stimulating agents and risk of brain hemorrhage in patients undergoing hemodialysis: the Q-Cohort Study
    Yushi Uchida
    Toshiaki Nakano
    Hiromasa Kitamura
    Masatomo Taniguchi
    Kazuhiko Tsuruya
    Takanari Kitazono
    Clinical and Experimental Nephrology, 2023, 27 : 79 - 88
  • [27] 10-year survival in patients undergoing cardiac resynchronization therapy
    Mazurek, M.
    Jedrzejczyk-Patej, E.
    Sokal, A.
    Gumprecht, J.
    Kotalczyk, A.
    Szulik, M.
    Pruszkowska, P.
    Kowalski, O.
    Lenarczyk, R.
    Kalarus, Z.
    EUROPEAN HEART JOURNAL, 2021, 42 : 936 - 936
  • [28] Apparent Treatment-Resistant Hypertension and Cardiovascular Risk in Hemodialysis Patients: Ten-Year Outcomes of the Q-Cohort Study
    Tanaka, Shigeru
    Ninomiya, Toshiharu
    Hiyamuta, Hiroto
    Taniguchi, Masatomo
    Tokumoto, Masanori
    Masutani, Kosuke
    Ooboshi, Hiroaki
    Nakano, Toshiaki
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] Serum alkaline phosphatase and infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-cohort study
    Kitamura, Hiromasa
    Yotsueda, Ryusuke
    Hiyamuta, Hiroto
    Taniguchi, Masatomo
    Tanaka, Shigeru
    Yamada, Shunsuke
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (11) : 1119 - 1129
  • [30] Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study
    Tanaka, Shigeru
    Nakano, Toshiaki
    Hiyamuta, Hiroto
    Taniguchi, Masatomo
    Tokumoto, Masanori
    Masutani, Kosuke
    Ooboshi, Hiroaki
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (04) : 385 - 395